Cleared Traditional

K151529 - Dimension Vista LOCI Total Testosterone Flex reagent cartridge, Dimension Vista Testosterone Calibrator

K151529 is an FDA 510(k) clearance for Dimension Vista LOCI Total Testosterone..., manufactured by Siemens Healthcare Diagnostics, Inc.. The device is a Class 1 Chemistry device with product code CDZ cleared through the Traditional 510(k) pathway after a 248-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2016
Decision
248d
Days
Class 1
Risk

K151529 is an FDA 510(k) clearance for the Dimension Vista LOCI Total Testosterone Flex reagent cartridge, Dimension Vis.... Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Siemens Healthcare Diagnostics, Inc. (Newark, US). The FDA issued a Cleared decision on February 11, 2016 after a review of 248 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Healthcare Diagnostics, Inc. devices

FDA 510(k) Submission Details - K151529

510(k) Number K151529 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 2015
Decision Date February 11, 2016
Days to Decision 248 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
160d slower than avg
Panel avg: 88d · This submission: 248d
Pathway characteristics
Predicate-based equivalence.

CDZ Device Classification - Class 1, General Controls

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 75
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K151529.
Free Testosterone AccuBind ELISA Test System
K181017 · Monobind, Inc. · Jul 2018
FREND Testosterone Test System
K153577 · Nanoentek USA, Inc. · Oct 2016
ADVA Centaur Testosterone II (TSTII), ADVA Centaur Testosterone II (TSTII) Master Curve Material, ADVIA Centaur SHBG, ADVIA Centaur SHBG Calibrator, ADVIA Centaur SHBG Master Curve Material
K151986 · Siemens Healthcare Diagnostics, Inc. · Jun 2016
ARCHITECT SHBG
K152185 · Biokit, S.A. · Feb 2016
ARCHITECT 2nd Generation Testosterone
K152155 · Abbott Laboratories · Dec 2015
ST AIA-PACK SHBG, ST AIA-PACK SHBG Calibrator Set
K143075 · Tosoh Bioscience, Inc. · Jul 2015